a b s t r a c t
This article contains data related to the research article entitled "Specification of embryonic stem cell-derived tissues into eye fields by Wnt signaling using rostral diencephalic tissue-inducing culture" Sakakura (2016) [1] . Mouse embryonic stem cells (ESC) were used for the generation of optic vesicle-like tissues in vitro. In this article we described data in which a Rax::GFP knock-in ESC line was used to monitor the formation of optic tissues. In addition, we also described the data of regional marker expression of Rax, Sox2 and Pax6 in vivo around the forebrain and the eye tissues for comparative purposes. These data can be valuable to researchers interested in investigating forebrain and eye tissue development. 
Value of the data
The expression pattern of Sox2, Pax6 and Rax provides the characterization of ESC-derived tissues for regional identification of neural tissues.
The data and diagram for the timed-addition of reagents into the differentiation media may assist the readers in readily using the in vitro system for inducing optic tissues from ESCs.
A data of the ESC-derived Rax positive tissues from culture day 4 to day 24 may give better information of the ESC differentiation culture for researchers in the related fields. 
Data
This data mainly focuses on describing the regional marker expression of neural tissues and the data of eye tissue-inducing culture ( Figs. 1 and 2) , and refers to our recently published [1] . We used mouse embryo and mouse ESC-derived tissue samples to analyze the regional marker expression via immunostaining and also showed the images of ESC-derived tissues in living condition. The data shown are microscopy images (Fluorescent and Bright-field), graphs (Population of GFPþ cells) and schematic diagrams (Step-by-step processes).
Experimental design, materials and methods

Regional marker expressions of neuroepithelium in vivo and in vitro
Rax was expressed in the anterior neuroepithelium, which expressed Sox2 as well at embryonic day (E) 7.75 ( Fig. 1A , A 0 ) [2, 3] . The optic tissues at E9.5 co-expressed Rax and Pax6 (Fig. 1D , D 0 ) [4] . Using a Rax::GFP ESC line, Raxþ tissues were locally induced at culture day 4, at which point Sox2 was globally expressed in the neuroepithelial-like structure (Fig. 1B, C) . Subsequently, by adding CHIR99021, Raxþ /Pax6 þ optic vesicle-like structures were formed at culture day 7, reminiscent of in vivo optic tissues (Fig. 1E, F ).
Step-by-step data during generating Raxþ optic vesicle-like tissues in the CDM/MG/CHIR condition
From here we describe data for generating Rax þ optic vesicle-like tissues using mouse ESCs ( Fig. 2A ). ESCs were maintained in maintenance medium before differentiation [5] (Fig. 2A, B) . At day 0, we performed SFEBq (Serum-free Floating culture of Embryoid Body-like aggregates with quick reaggregation) [6] . ESCs were dissociated and quickly aggregated in the non-adhesion coated 96 wells (Fig. 2D) . 30 min later, we could observe the beginning of aggregation and, 6 h later, cells had mostly aggregated (Fig. 2C, E) . At day 1, 2% matrigel was directly added into the medium (Fig. 2F) . At day 2, the surface portion of the day-2 aggregate was changed morphologically (Fig. 2G) . By day 4, neurorpithelial-like structures expressing apico-basal polarity marker, N-cadherin (inside), and Laminin (outside) were observed (Fig. 2H, J) . Simultaneously, Rax::GFP cells started to faintly appear in the epithelial-like structure (Fig. 2I, K) . This time (day 4), 2 mM CHIIR99021 was added, which inhibited GSK-3ß. At day 7, Raxþ optic vesicle-like structures were generated (Fig. 2L, M) . Subsequently, at day 7, we replaced CDM with DMEM/F12/N2/10% FBS (fetal bovine serum) medium to grow tissues for long-term culture ( Fig. 2A) . At day 10, we chopped Rax þ tissue portions which also expressed Pax6 in order to separate them from other tissues (Fig. 2N ). From day 10, we precisely followed the method reported previously [5] . We confirmed that day-18 tissues mostly expressed Rax::GFP (Fig. 2O, O 0 ) and day-24 tissues expressed Rax::GFP and Recoverin, which is expressed in the photoreceptor cells of the eyes in vivo [7, 8] (Fig. 2P ). The addition of 0.5 or 3 mM CHIR99021 from day 4 to day 7 did not efficiently: induce the formation of Raxþ vesicle-like structure (Fig. 2Q ).
ESC culture and reagents
ES cell maintenance; Using ESC-qualified Fetal calf serum (FCS) and KnockOut Serum Replacement, a Rax::GFP knock-in ESC line was maintained as described previously [5] . ES cell differentiation; Based on SFEBq using Nunclon Sphera 96U Bottom Plate (Thermo Scientific, 174925) [6] , the differentiation method was performed in the CDM/MG/CHIR condition for inducing Rax þ optic vesicle-like tissues. CDM was prepared as follows: IMDM, GlutaMAX™ Supplement (Thermo Fisher Scientific, 31980030)/ Ham's F-12 Nutrient Mix, GlutaMAX™ Supplement (Thermo Fisher Scientific, 31765035) 1:1, 1x Chemically Defined Lipid Concentrate (Thermo Fisher Scientific, 11905031), 450 mM 1-Thioglycerol (SIGMA-ALDRICH, M6145), 5 mg/ml Bovine Serum Albumin (SIGMA-ALDRICH, A3156) and 15 mg/ml apo-Transferrin bovine (SIGMA-ALDRICH, T1428). At day 0, ESC were dissociated into single cells and the number of cells was counted via trypan-blue staining (SIGMA-ALDRICH, T8154 for excluding dead cells) to seed 3000 cells per well in CDM. At day 1, 2% (vol/vol) of matrigel, growth factor reduced (BD, 354230) were added. The final protein concentration of matrigel is typically 200 mg/ml (from around 10 mg/ml protein concentration) and several matrigel lots are routinely tested using a previous eye inducing protocol [5] . At day 4, 2 mM CHIR99021 (STEMGENT, 04-0004) was added. Infrequently, ESC-derived tissue at day 4 does not expressed Rax::GFP (typically due to ESC-passage number or incorrect ESC maintenance state). In this case, the addition of CHIR99021 led to the formation of Rax negative tissues at day 7 (data not shown). At day 7, ESC-derived tissues were transferred into DMEM/F12/N2/Penicillin-Streptomycin (PS), containing 10% FBS (vol/vol). At day 10, from here, ESC-derived tissue were grown exactly the same as previously published [5] , and its process is also briefly shown in Fig. 2A .
Immunostaining and acquiring images
Slc:ICR mouse embryos were purchased from Japan SLC, Inc. to serve as a positive control. Immunostaining of cryosectioned samples was performed as previously described [9] . Primary antibodies were used as follows: GFP (rat, 1/500, NACALAI, 04404-84), Sox2 (goat, 1/250, santa cruz, sc-17320), Rax (guinea pig, 1/1000, TaKaRa custum, MS8407-3), Pax6 (mouse, 1/500, R&D, MAB1260), N-cadherin (mouse, 1/1000, BD, 610920), Laminin (rat, 1/1000, CHEMICON, MAB1905) and Recoverin (rabbit, 1/1000, chemicon, AB5585). DAPI was used for counter staining. Immunofluorescent images were taken by LSM710 or 780 (Zeiss). For the visualization of living ESCs and ESC-derived tissues, KEYENCE (KEYENCE) and EVOS (Thermo Fisher) microscopes were used. Acquired images were merged using Photoshop and ImageJ softwares.
Fluorescence-activated cell sorting (FACS) analysis
FACS analysis was performed as previously described [9] .
